Pharmacoepidemiology

PrimeVigilance’s multi–disciplinary team is led by Dr. Michael Forstner, Head of Pharmacoepidemiology and Risk Management.

As a well-known and respected expert in the design and implementation of evidence based studies, along with cutting-edge methods in both pharmacovigilance planning and risk management, PrimeVigilance is a unique industry partner.